Overexpression of NNT-AS1 Activates TGF-β Signaling to Decrease Tumor CD4 Lymphocyte Infiltration in Hepatocellular Carcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overexpression of NNT-AS1 Activates TGF-β Signaling to Decrease Tumor CD4 Lymphocyte Infiltration in Hepatocellular Carcinoma
Authors
Keywords
-
Journal
Biomed Research International
Volume 2020, Issue -, Pages 1-11
Publisher
Hindawi Limited
Online
2020-12-25
DOI
10.1155/2020/8216541
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long non-coding RNA NNT-AS1 promotes cholangiocarcinoma cells proliferation and epithelial-to-mesenchymal transition through down-regulating miR-203
- (2020) Yulei Gu et al. Aging-US
- Systematic Review of the Roles of Interleukins in Hepatocellular Carcinoma
- (2020) Hu Yang et al. CLINICA CHIMICA ACTA
- LncRNA NNT-AS1 promotes lung squamous cell carcinoma progression by regulating the miR-22/FOXM1 axis
- (2020) Jing Ma et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- Interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma
- (2020) Laura-Sophie Landwehr et al. Journal for ImmunoTherapy of Cancer
- LncRNA MEG8 promotes tumor progression of non-small cell lung cancer via regulating miR-107/CDK6 axis
- (2020) Ying Liu et al. ANTI-CANCER DRUGS
- Transforming Growth Factor-β Signaling in Immunity and Cancer
- (2019) Eduard Batlle et al. IMMUNITY
- Multiplex fluorescent immunohistochemistry quantitatively analyses microvascular density (MVD) and the roles of TGF-β signalling in orchestrating angiogenesis in colorectal cancer
- (2019) Lei Yang et al. Translational Cancer Research
- Downregulation of nicotinamide nucleotide transhydrogenase and its naturally occurring antisense RNA in gastric cancer
- (2019) Farbod Esfandi et al. Asia-Pacific Journal of Clinical Oncology
- Hepatocellular carcinoma: Mechanisms of progression and immunotherapy
- (2019) Yu Jiang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The Immune Landscape of Cancer
- (2019) Vésteinn Thorsson et al. IMMUNITY
- FAM83H-AS1 is upregulated and predicts poor prognosis in colon cancer
- (2019) Lei Yang et al. BIOMEDICINE & PHARMACOTHERAPY
- Long non-coding RNA NNT-AS1 affects progression of breast cancer through miR-142-3p/ZEB1 axis
- (2018) Yan Li et al. BIOMEDICINE & PHARMACOTHERAPY
- TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis
- (2018) Daniele V. F. Tauriello et al. NATURE
- Long noncoding RNA VPS9D1-AS1 overexpression predicts a poor prognosis in non-small cell lung cancer
- (2018) Jinjing Tan et al. BIOMEDICINE & PHARMACOTHERAPY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a
- (2018) Changhui Li et al. CANCER BIOLOGY & THERAPY
- Long noncoding RNA NNT-AS1 promotes gastric cancer proliferation and invasion by regulating microRNA-363 expression
- (2018) Xin Wang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Profiling cytochrome P450 family 4 gene expression in human hepatocellular carcinoma
- (2018) Hyuk Soo Eun et al. Molecular Medicine Reports
- Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy
- (2017) Jingying Zhou et al. GUT
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Systemic Therapy for Hepatocellular Carcinoma: 2017 Update
- (2017) Masatoshi Kudo ONCOLOGY
- Long Noncoding RNAs in Cancer Pathways
- (2016) Adam M. Schmitt et al. CANCER CELL
- The long non-coding RNA, SNHG6-003, functions as a competing endogenous RNA to promote the progression of hepatocellular carcinoma
- (2016) C Cao et al. ONCOGENE
- TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology
- (2016) Masato Morikawa et al. Cold Spring Harbor Perspectives in Biology
- Brief-exposure to preoperative bevacizumab reveals a TGF-β signature predictive of response in HER2-negative breast cancers
- (2015) Vinay Varadan et al. INTERNATIONAL JOURNAL OF CANCER
- The emerging role of lncRNAs in cancer
- (2015) Maite Huarte NATURE MEDICINE
- CUDR promotes liver cancer stem cell growth through upregulating TERT and C-Myc
- (2015) Hu Pu et al. Oncotarget
- Type III TGF-β receptor downregulation generates an immunotolerant tumor microenvironment
- (2013) Brent A. Hanks et al. JOURNAL OF CLINICAL INVESTIGATION
- Regulatory T Cell Infiltration Predicts Outcome Following Resection of Colorectal Cancer Liver Metastases
- (2012) Steven C. Katz et al. ANNALS OF SURGICAL ONCOLOGY
- Elevation of Highly Up-regulated in Liver Cancer (HULC) by Hepatitis B Virus X Protein Promotes Hepatoma Cell Proliferation via Down-regulating p18
- (2012) Yumei Du et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A critical function for TGF-β signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells
- (2008) Yongzhong Liu et al. NATURE IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started